Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04267211 · ClinicalTrials.gov registry record · NA
Prenatal Consult With Illustrated Literature
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
NCT04267211: Completed NA study, sponsored by University of Virginia.
NCT04267211 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 82 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04267211, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
Study Summary
The overall purpose of this study is to determine whether implementing a 'Prenatal Consult Bundle' to the existing prenatal consult, including provision of sample questions, added discussion points and handouts, and a return visit, will decrease parental anxiety and improve information recall. Additionally, this study will determine if this effect is further increased with the use of illustrated literature.
Primary Outcome
Using the State-Trait Anxiety Inventory (STAI), maternal anxiety will be assessed between the two groups
Interventions
- OTHER Illustrated handout at prenatal consult
- OTHER Standard Prenatal Consult
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2017-06-05 |
| Est. Completion | 2019-06-04 |
| Phase | NA |
What the finished NCT04267211 record still lists
NCT04267211 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Illustrated handout at prenatal consult is the first listed.
NCT04267211 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04267211 about?
NCT04267211 is a clinical study titled "Prenatal Consult With Illustrated Literature". The overall purpose of this study is to determine whether implementing a 'Prenatal Consult Bundle' to the existing prenatal consult, including provision of sample questions, added discussion points and handouts, and a return visit, will decrease parental anxiety and improve information recall. Addit...
What is the current status of trial NCT04267211?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2017-06-05. Estimated completion is 2019-06-04.
What interventions are being tested in trial NCT04267211?
The interventions under investigation include: Illustrated handout at prenatal consult (OTHER), Standard Prenatal Consult (OTHER).
Who is sponsoring clinical trial NCT04267211?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04267211's enrollment target sits among peer trials
82 990th of 2000 higher than 1,009 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI